Biotech Watch List: Coronado Biosciences (NASDAQ:CNDO), Agenus (NASDAQ:AGEN), Synthetic Biologics (NYSEMKT:SYN), Athersys (NASDAQ:ATHX)


Agenus Inc (NASDAQ:AGEN) will release its first quarter 2014 financial results before the market opens on May 8, 2014. Agenus executives will host a conference call at 11:00 a.m. Eastern Time that same day. To access the live call, dial 647-426-1845. A replay will be available approximately two hours after the call through midnight Eastern Time on July 8, 2014. The replay number is 416-915-1035, and the access code is 571716. The replay will also be available on the company’s website approximately two hours after the live call. Agenus Inc (NASDAQ:AGEN) after opening at $2.78, moved down -1.79% to $2.74 on last trading day. Company’s 52 week range is $2.66 – $2.94.

On April 30, 2014, Synthetic Biologics Inc (NYSEMKT:SYN), will host a conference call today to discuss in further detail the topline Phase II study results of Trimesta™ (oral estriol), which the Company is developing as a once-daily adjunctive oral treatment for relapsing-remitting multiple sclerosis (RRMS) in women. Topline data were announced yesterday by the University of California, Los Angeles (UCLA) School of Medicine and presented at the 66th Annual Meeting of the American Academy of Neurology by the study’s lead investigator, Rhonda Voskuhl, M.D., Professor, Department of Neurology, Jack H. Skirball Chair in Multiple Sclerosis Research and Director, Multiple Sclerosis Program at UCLA David Geffen School of Medicine. Synthetic Biologics Inc (NYSEMKT:SYN) stock hit highest price at $1.51, beginning with a price of $1.46 and decreased -9.41% to the close at $1.30 with day range of $1.30 – $1.51. The total market capitalization of the stock is $75.76 billion.

Athersys, Inc. (NASDAQ:ATHX) saw a big move last session, as the company’s shares fell by over 51% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for ATHX, as the stock is now down around 61% since April 1.
Athersys, Inc. (NASDAQ:ATHX) stock traded in the range of $1.40 – $1.67 and at the end of the day, it closed at $1.63. Average trading volume of the company is $2.01M. Athersys, Inc. (NASDAQ:ATHX)return on equity ratio is recorded as -218.90% and its return on assets is -124.40%.

Shares of Coronado Biosciences Inc (NASDAQ:CNDO)closed at $1.67 in last trading session. Yesterday share price of the company was traded in the range of $1.61 to $1.75. Company now has a market value of $73.81 billion. Coronado Biosciences Inc (NASDAQ:CNDO)price to cash ratio in past twelve months was calculated as0.74.


Leave a Reply

Your email address will not be published. Required fields are marked *